Fujirebio Lumipulse G β-Amyloid 1-42-N Plasma Calibrators recalled for inaccurate Alzheimer's disease test results
Stop using Fujirebio Lumipulse calibrators
Fujirebio Diagnostics is recalling calibrator kits (model 235454, specific lot numbers) used in a blood test for Alzheimer's disease risk. The calibrators may cause inaccurate results, falsely flagging patients as positive or indeterminate for amyloid pathology when they should not be, or missing cases that should be detected.
- If your medical provider used this test kit, contact them immediately to discuss your results and whether retesting is needed.
- Do not use lot numbers D8C6022U or D8C6044U of this product.
- Healthcare facilities: check your inventory and stop using affected lots; consult Fujirebio for guidance on potentially affected patient results.
Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result).
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1306-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief